Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alvar Agusti

Showing results (41-50 of 237) with videos related to

Pageof 24
Sort By:
The Lancet. Respiratory Medicine|April 12, 2021
Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19Alvar Agusti, Ferran Torres, Rosa Faner
American Journal of Respiratory and Critical Care Medicine|September 21, 2023
Microbiological Monitoring in Therapeutic Trials in Chronic Obstructive Pulmonary DiseaseMiguel Angel Martinez-Garcia, Alvar Agusti
Respirology (Carlton, Vic.)|July 15, 2015
Biomarkers, the control panel and personalized COPD medicineAlvar Agusti, Joaquim Gea, Rosa Faner
Chest|November 7, 2022
Rebuttal From Drs Martinez-Garcia and AgustiMiguel Ángel Martínez-García, Alvar Agusti
Respiratory Medicine|October 15, 2025
Treatable Traits. Why, What, How?Alvar Agusti, Peter Gibson, Mario Cazzola
Nature Reviews. Drug Discovery|September 22, 2025
Treatment of chronic obstructive pulmonary disease: current pipeline and new opportunitiesAlvar Agusti, Dave Singh, Rosa Faner
The European Respiratory Journal|March 5, 2021
Transitioning from infancy to adulthood: a black box full of opportunitiesAlvar Agusti, Robab Breyer-Kohansal, Rosa Faner
Chest|May 8, 2009
Investigating the natural history of lung function: facts, pitfalls, and opportunitiesRobab Kohansal, Joan B Soriano, Alvar Agusti
The New England Journal of Medicine|June 5, 2009
Immunologic aspects of chronic obstructive pulmonary diseaseManuel G Cosio, Marina Saetta, Alvar Agusti
Thorax|June 10, 2011
Cardiovascular mechanisms of death in severe COPD exacerbation: time to think and act beyond guidelinesLeonardo M Fabbri, Bianca Beghé, Alvar Agusti
Pageof 24

Showing results (41-50 of 237) with videos related to

Sort By:
Pageof 24
The Lancet. Respiratory Medicine|April 12, 2021
Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19Alvar Agusti, Ferran Torres, Rosa Faner
American Journal of Respiratory and Critical Care Medicine|September 21, 2023
Microbiological Monitoring in Therapeutic Trials in Chronic Obstructive Pulmonary DiseaseMiguel Angel Martinez-Garcia, Alvar Agusti
Respirology (Carlton, Vic.)|July 15, 2015
Biomarkers, the control panel and personalized COPD medicineAlvar Agusti, Joaquim Gea, Rosa Faner
Chest|November 7, 2022
Rebuttal From Drs Martinez-Garcia and AgustiMiguel Ángel Martínez-García, Alvar Agusti
Respiratory Medicine|October 15, 2025
Treatable Traits. Why, What, How?Alvar Agusti, Peter Gibson, Mario Cazzola
Nature Reviews. Drug Discovery|September 22, 2025
Treatment of chronic obstructive pulmonary disease: current pipeline and new opportunitiesAlvar Agusti, Dave Singh, Rosa Faner
The European Respiratory Journal|March 5, 2021
Transitioning from infancy to adulthood: a black box full of opportunitiesAlvar Agusti, Robab Breyer-Kohansal, Rosa Faner
Chest|May 8, 2009
Investigating the natural history of lung function: facts, pitfalls, and opportunitiesRobab Kohansal, Joan B Soriano, Alvar Agusti
The New England Journal of Medicine|June 5, 2009
Immunologic aspects of chronic obstructive pulmonary diseaseManuel G Cosio, Marina Saetta, Alvar Agusti
Thorax|June 10, 2011
Cardiovascular mechanisms of death in severe COPD exacerbation: time to think and act beyond guidelinesLeonardo M Fabbri, Bianca Beghé, Alvar Agusti
Pageof 24